Yili Chuanning Biotechnology Co., Ltd.

Yili Chuanning Biotechnology Co., Ltd. was invested by Kelun Pharmaceutical Group in 2010 and was established in 2011 in Yining Park of the National KHorgos Economic Development Zone. It adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving and environmental protection technologies. There are currently more than 2,000 employees, covering 25 ethnic groups. The main products, erythromycin thiocyanate (7704-67-8), penicillin G potassium salt (113-98-4), 6-aminopenicillanic acid (6-APA, 551-16-6), 7-aminocephalosporanic acid (7-ACA, 957-68-6), 7-aminodeacetoxycephalosporanic acid (7-ADCA, 26395-99-3), Deacetyl-7-aminocephalosporanic acid (D-7-ACA, 15690-38-7), Ursodeoxycholic acid (UDCA, 128-13-2), etc., are widely sold home and abroad.